Dibucaine hydrochloride

盐酸辛可卡因

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDibucaine hydrochloride
Drug Alias Name地布卡因Cincaini ChloridumNupercaine Hydrochloride纽白卡因Cinchocaine Hydrochloride +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type V alpha subunit blockersSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type V alpha subunitSodium channel protein type X alpha subunit
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeC05AD04D04AB02N01BB06 +[5